SAENGER BRADLEY 5
5 · Tonix Pharmaceuticals Holding Corp. · Filed Feb 17, 2026
Insider Transaction Report
Form 5
SAENGER BRADLEY
Chief Financial Officer
Transactions
- Award
Common Stock, par value $0.001
[F1]2025-12-31$13.42/sh+701$9,407→ 701 total
Footnotes (1)
- [F1]Shares acquired through the Tonix Pharmaceuticals Holding Corp. 2025 Employee Stock Purchase Plan.
Signature
/s/ Bradley Saenger|2026-02-17